Premium
Involvement of SH2‐SH2‐SH3 domain of phospholipase Cγ1 in NF‐κB signaling
Author(s) -
Kim Bo-Yeon,
Kang Dae-Ook,
Oh Won-Keun,
Kim Jin-Hee,
Choi Yong-Kyung,
Jang Jong-Soo,
Suh Pann-Ghill,
Ryu Sung-Ho,
Mheen Tae-Ick,
Ahn Jong-Seog
Publication year - 2000
Publication title -
febs letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.593
H-Index - 257
eISSN - 1873-3468
pISSN - 0014-5793
DOI - 10.1016/s0014-5793(00)01415-0
Subject(s) - sh2 domain , chemistry , grb2 , sh3 domain , signal transduction , proto oncogene tyrosine protein kinase src , microbiology and biotechnology , biochemistry , biology
To directly define the role of phospholipase Cγ1 (PLCγ1) in NF‐κB activation, NF‐κB promoted luciferase reporter gene plasmid (pNF‐κB‐Luc) was transfected into rat‐3Y1 fibroblasts that overexpress whole PLCγ1 (PLCγ1‐3Y1), src homology domains SH2‐SH2‐SH3 of PLCγ1 (SH223‐3Y1) and v‐src (Src‐3Y1). Transient transfection with pNF‐κB‐Luc remarkably increased the luciferase activity in all three transformants compared with normal rat‐3Y1 cells. Pretreatment with inhibitors of protein tyrosine kinase reduced this increase in luciferase activity, but U73122 (a PLC inhibitor) did not. While PD98059, an inhibitor of mitogen activated protein kinase (MAPK), significantly reduced the luciferase activity, there was no effect by wortmannin and Ro‐31‐8220, inhibitors of phosphatidylinositol 3‐kinase (PI3K) and protein kinase C (PKC), respectively. This study shows a direct evidence that the SH2‐SH2‐SH3 region of PLCγ1 contributes to the NF‐κB signaling and that MAPK, but not PI3K and PKC, is involved in SH2‐SH2‐SH3 mediated NF‐κB activation in these cells.